XWELL Price to Sales Ratio 2010-2025 | XWEL
Historical PS ratio values for XWELL (XWEL) over the last 10 years. The current P/S ratio for XWELL as of May 21, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| XWELL P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-05-22 | 0.92 | 0.13 | |
| 2025-03-31 | 1.02 | $6.92 | 0.15 |
| 2024-12-31 | 1.51 | $7.67 | 0.20 |
| 2024-09-30 | 1.73 | $7.83 | 0.22 |
| 2024-06-30 | 1.80 | $7.87 | 0.23 |
| 2024-03-31 | 1.69 | $7.61 | 0.22 |
| 2023-12-31 | 1.74 | $7.22 | 0.24 |
| 2023-09-30 | 2.25 | $7.06 | 0.32 |
| 2023-06-30 | 4.00 | $7.54 | 0.53 |
| 2023-03-31 | 7.20 | $8.43 | 0.85 |
| 2022-12-31 | 7.20 | $11.47 | 0.63 |
| 2022-09-30 | 15.40 | $15.44 | 1.00 |
| 2022-06-30 | 13.80 | $18.23 | 0.76 |
| 2022-03-31 | 22.60 | $17.10 | 1.32 |
| 2021-12-31 | 40.40 | $14.05 | 2.88 |
| 2021-09-30 | 29.40 | $8.61 | 3.42 |
| 2021-06-30 | 30.80 | $3.62 | 8.51 |
| 2021-03-31 | 36.80 | $1.97 | 18.69 |
| 2020-12-31 | 23.80 | $24.88 | 0.96 |
| 2020-09-30 | 39.40 | $157.49 | 0.25 |
| 2020-06-30 | 83.80 | $244.56 | 0.34 |
| 2020-03-31 | 11.40 | $636.83 | 0.02 |
| 2019-12-31 | 40.20 | $1,008.03 | 0.04 |
| 2019-09-30 | 86.40 | $1,351.89 | 0.06 |
| 2019-06-30 | 116.40 | $1,812.29 | 0.06 |
| 2019-03-31 | 144.00 | $2,002.00 | 0.07 |
| 2018-12-31 | 192.00 | $2,197.76 | 0.09 |
| 2018-09-30 | 180.00 | $2,364.16 | 0.08 |
| 2018-06-30 | 348.00 | $2,456.02 | 0.14 |
| 2018-03-31 | 864.00 | $2,676.88 | 0.32 |
| 2017-12-31 | 1644.00 | $2,791.32 | 0.59 |
| 2017-09-30 | 1668.00 | $1,790.45 | 0.93 |
| 2017-06-30 | 1980.00 | $1,391.44 | 1.42 |
| 2017-03-31 | 2604.00 | $1,496.52 | 1.74 |
| 2016-12-31 | 2556.00 | $963.75 | 2.65 |
| 2016-09-30 | 3228.00 | $3,973.02 | 0.81 |
| 2016-06-30 | 2268.00 | $3,732.63 | 0.61 |
| 2016-03-31 | 1968.00 | $2,824.63 | 0.70 |
| 2015-12-31 | 2964.00 | $2,670.64 | 1.11 |
| 2015-09-30 | 6720.00 | $49.23 | 136.50 |
| 2015-06-30 | 6720.00 | $68.71 | 97.80 |
| 2015-03-31 | 7800.00 | $176.82 | 44.11 |
| 2014-12-31 | 6600.00 | $192.80 | 34.23 |
| 2014-09-30 | 11400.00 | $162.80 | 70.02 |
| 2014-06-30 | 41040.00 | $143.32 | 286.35 |
| 2014-03-31 | 41640.00 | $194.63 | 213.94 |
| 2013-12-31 | 35520.00 | $159.42 | 222.81 |
| 2013-09-30 | 34440.00 | $111.99 | 307.52 |
| 2013-06-30 | 38040.00 | $166.28 | 228.77 |
| 2013-03-31 | 38040.00 | $6.86 | 5547.50 |
| 2012-12-31 | 34440.00 | $6.86 | 5022.50 |
| 2012-09-30 | 34800.00 | $54.29 | 641.05 |
| 2012-06-30 | 46320.00 | 0 | 0.00 |
| 2012-03-31 | 19800.00 | $454.00 | 43.61 |
| 2011-12-31 | 11880.00 | $748.00 | 15.88 |
| 2011-09-30 | 17040.00 | $1,024.67 | 16.63 |
| 2011-06-30 | 14640.00 | $1,132.67 | 12.93 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.005B | $0.034B |
| XWELL Inc. is a health and wellness holding company. Its operating brands include XpresCheck(R), XpresSpa(R), Treat(TM) and HyperPointe. XpresSpa is a retailer of wellness services and related products. Treat is a travel health and wellness brand. XpresCheck is a provider of Covid-19 screening and diagnostic testing in partnership with the CDC and Concentric by Ginkgo. HyperPointe is a digital healthcare and data analytics relationship company. XWELL Inc., formerly known as XpresSpa Group Inc., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $133.694B | 25.08 |
| Elevance Health (ELV) | United States | $90.401B | 11.66 |
| CVS Health (CVS) | United States | $78.570B | 9.77 |
| Cencora (COR) | United States | $56.472B | 19.65 |
| DiDi Global (DIDIY) | China | $22.450B | 34.07 |
| Natera (NTRA) | United States | $20.631B | 0.00 |
| BioMerieux (BMXMF) | France | $15.355B | 0.00 |
| Solventum (SOLV) | United States | $12.588B | 13.33 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.514B | 0.00 |
| CochLear (CHEOY) | Australia | $11.382B | 0.00 |
| Revvity (RVTY) | United States | $10.588B | 18.22 |
| ICON (ICLR) | Ireland | $10.225B | 9.51 |
| Viatris (VTRS) | United States | $9.953B | 3.42 |
| Doximity (DOCS) | United States | $9.475B | 44.13 |
| Avantor (AVTR) | United States | $8.552B | 12.43 |
| HealthEquity (HQY) | United States | $8.545B | 42.04 |
| Medpace Holdings (MEDP) | United States | $8.501B | 22.58 |
| Sonic Healthcare (SKHHY) | Australia | $8.263B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.630B | 12.99 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| BrightSpring Health Services (BTSG) | United States | $4.137B | 38.29 |
| Bausch + Lomb (BLCO) | Canada | $3.955B | 23.31 |
| Sotera Health (SHC) | United States | $3.503B | 19.90 |
| Alignment Healthcare (ALHC) | United States | $3.033B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.905B | 37.78 |
| Concentras Parent (CON) | United States | $2.803B | 16.20 |
| Organon (OGN) | United States | $2.191B | 2.33 |
| Ardent Health Partners (ARDT) | United States | $2.137B | 9.11 |
| GeneDx Holdings (WGS) | United States | $1.934B | 74.48 |
| Premier (PINC) | United States | $1.899B | 14.41 |
| Progyny (PGNY) | United States | $1.816B | 39.98 |
| PACS (PACS) | United States | $1.506B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.354B | 27.07 |
| Pediatrix Medical (MD) | United States | $1.303B | 9.91 |
| Teladoc Health (TDOC) | United States | $1.223B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.037B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| Agilon Health (AGL) | United States | $0.973B | 0.00 |
| CareDx (CDNA) | United States | $0.949B | 14.83 |
| Nutex Health (NUTX) | United States | $0.941B | 14.21 |
| AMN Healthcare Services Inc (AMN) | United States | $0.846B | 7.92 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| Embecta (EMBC) | United States | $0.722B | 4.86 |
| InnovAge Holding (INNV) | United States | $0.554B | 0.00 |
| Enhabit (EHAB) | United States | $0.528B | 43.46 |
| Auna S.A (AUNA) | Luxembourg | $0.506B | 11.40 |
| LifeMD (LFMD) | United States | $0.489B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.467B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.403B | 0.00 |
| SBC Medicals (SBC) | United States | $0.360B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.204B | 0.00 |
| Oncology Institute (TOI) | United States | $0.202B | 0.00 |
| Beauty Health (SKIN) | United States | $0.195B | 0.00 |
| KindlyMD (KDLY) | United States | $0.137B | 0.00 |
| DocGo (DCGO) | United States | $0.131B | 21.33 |
| So-Young (SY) | China | $0.089B | 0.00 |
| OncoCyte (OCX) | United States | $0.088B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.072B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| Biodesix (BDSX) | United States | $0.058B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.036B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.035B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| ModivCare (MODV) | United States | $0.013B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |